Akums Drugs and Pharmaceutical (AKUMS) — Capital Reinvestment Ratio
Akums Drugs and Pharmaceutical (AKUMS) has a Capital Reinvestment Ratio of 0.59x as of March 2025, meaning it reinvests 1% of its operating cash flow (Rs4.65 Billion) in capital expenditures (Rs2.72 Billion). See Akums Drugs and Pharmaceutical free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Akums Drugs and Pharmaceutical Capital Reinvestment Ratio (2022–2025)
This chart tracks Akums Drugs and Pharmaceutical's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Akums Drugs and Pharmaceutical (2022–2025)
Year-by-year Capital Reinvestment Ratio for Akums Drugs and Pharmaceutical from 2022 to 2025. For live market cap and broader valuation context, see Akums Drugs and Pharmaceutical stock valuation.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.59x | Rs4.65 Billion | Rs2.72 Billion | ▼ -6.3% |
| 2024 | 0.62x | Rs4.98 Billion | Rs3.11 Billion | ▼ -66.4% |
| 2023 | 1.86x | Rs1.77 Billion | Rs3.29 Billion | ▼ -77.0% |
| 2022 | 8.09x | Rs318.54 Million | Rs2.58 Billion | — |